Équilibre Biopharmaceuticals
Debra L. Maierhofer is Vice President of Pharmacovigilance and Medical Affairs at Équilibre Biopharmaceutical Corp. Prior to joining Équilibre, Ms. Maierhofer founded, built and developed the Pharmacovigilance and Medical Affairs departments for Kadmon Corporation, LLC.
In addition to leading the Pharmacovigilance and Medical Affairs departments, at Équilibre, Ms. Maierhofer collaborates with management to develop the leading quality management systems, including the development of vendor qualification, procedural documents and the implementation of validated quality systems.
Ms. Maierhofer graduated with honors from Gannon University which she earned her B.S.B.A.; Management and Marketing. She later continued her education to pursue a career as a Registered Nurse, advancing into Management. Ms. Maierhofer has been working in the field of Pharmacovigilance for over 20 years for pharmacovigilance organizations (GlaxoSmithKline and Kadmon Corporation) and Clinical Research Organization, PPD.
This person is not in any offices
Équilibre Biopharmaceuticals
Équilibre Biopharmaceuticals Corp. was established as an innovative biopharmaceutical company focused on identifying and developing high-potential drugs for patients who are treatment-resistant or unresponsive to other existing medications.